Douglas Holtzman
Chief Tech/Sci/R&D Officer chez ICOSAVAX, INC.
Profil
Douglas Holtzman is the founder of Palindrome Bioconsulting LLC, which was founded in 2016.
He is currently the Chief Scientific Officer at Icosavax, Inc. since 2019.
Previously, he worked as the Deputy Director-Childhood Pneumonia at Bill & Melinda Gates Foundation from 2004 to 2012, and as the Vice President-Discovery at Takeda Pharmaceuticals U.S.A., Inc. from 2012 to 2016.
Holtzman received his undergraduate degree from Tufts University, his doctorate from the University of California, Berkeley, and his graduate degree from Harvard T.H.
Chan School of Public Health.
Postes actifs de Douglas Holtzman
| Sociétés | Poste | Début |
|---|---|---|
| ICOSAVAX, INC. | Chief Tech/Sci/R&D Officer | 01/08/2019 |
Anciens postes connus de Douglas Holtzman
| Sociétés | Poste | Fin |
|---|---|---|
| Palindrome Bioconsulting LLC | Founder | 01/08/2019 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/07/2016 |
Bill & Melinda Gates Foundation
 Bill & Melinda Gates Foundation Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Foundation is a nonprofit organization that aims to help people lead healthy and productive lives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. The company's mission is to create a world where everyone has equal opportunities. The company is guided by the belief that every life has equal value. The foundation is currently working on 'the big catch-up' project, which aims to increase vaccination levels among children to pre-pandemic levels and strengthen primary healthcare services for essential immunization in the future. The company was founded by Melinda French Gates and William H. Gates, and the CEO is Mark Suzman. | Corporate Officer/Principal | 01/01/2012 |
Formation de Douglas Holtzman
| Tufts University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Foundation is a nonprofit organization that aims to help people lead healthy and productive lives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. The company's mission is to create a world where everyone has equal opportunities. The company is guided by the belief that every life has equal value. The foundation is currently working on 'the big catch-up' project, which aims to increase vaccination levels among children to pre-pandemic levels and strengthen primary healthcare services for essential immunization in the future. The company was founded by Melinda French Gates and William H. Gates, and the CEO is Mark Suzman. | Commercial Services |
| Palindrome Bioconsulting LLC |
